We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Cayman Δ8-Tetrahydrocannabivarin Acetate (exempt preparation)
Product Description
Oxaloacetic acid is an α-keto acid and a key component of cellular metabolism in its conjugate base form, oxaloacetate.,, Oxaloacetate reacts with acetyl-coenzyme A (acetyl-CoA; Item No. ) and water to form citrate in the first step of the citric acid cycle and is regenerated by oxidation of L-malate in the final step. It is an intermediate in gluconeogenesis that is formed in mitochondria via carboxylation of pyruvate and subsequently decarboxylated and phosphorylated to form phosphoenolpyruvate. It can be converted to aspartate via addition of an amino group from glutamate. Oxaloacetate (30 μmol/min per 100 g for 30 minutes, i.v.) reduces blood glutamate levels, severity of neurological dysfunction, and brain edema in a rat model of closed head injury.
WARNING This product is not for human or veterinary use.
Technical Information
- NSC 284205
- NSC 77688
- OAA
- Oxalacetic Acid
- DMF: 15mg/mL
- DMSO: 15mg/mL
- Ethanol: 15mg/mL
Shipping & Storage Information
| SKU | CAYM-39443-1 |
|---|---|
| Featured | No |
| Supplier Part Number | 39443-1 |
| UM | EA |
| UNSPSC | 12352200 |
| Manufacturer | Cayman |
| Temperature | -20 |
| Refrigerated-Frozen | Refrigerated |
| CountryOfOrigin | United States |
| ProductLine | CAYM |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 2 |
| Hazardous | Y |
| Energy Star | No |
| Green | No |
| ACT Ecolabel | No |
| Controlled | N |